Human Wharton's Jelly-Derived Stem Cells Display a Distinct Immunomodulatory and Proregenerative Transcriptional Signature Compared to Bone Marrow-Derived Stem Cells

Raf Donders, Jeroen F. J. Bogie, Stylianos Ravanidis, Pascal Gervois, Marjan Vanheusden, Raphael Maree, Marie Schrynemackers, Hubert J. M. Smeets, Jef Pinxteren, Kristel Gijbels, Sara Walbers, Robert W. Mays, Robert Deans, Ludo Van Den Bosch, Piet Stinissen, Ivo Lambrichts, Wilfried Gyselaers, Niels Hellings

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)65-84
Number of pages20
JournalStem Cells and Development
Volume27
Issue number2
DOIs
Publication statusPublished - 1 Jan 2018

Keywords

  • umbilical cord
  • microarray
  • MAPC
  • MSC
  • neurotrophic factors
  • immune modulation
  • HUMAN UMBILICAL-CORD
  • ADULT PROGENITOR CELLS
  • MESENCHYMAL STROMAL CELLS
  • CLINICAL-APPLICATIONS
  • PHENOTYPIC CHARACTERIZATION
  • DIFFERENTIATION CAPACITY
  • REGENERATIVE MEDICINE
  • CULTURE-CONDITIONS
  • ISCHEMIC-STROKE
  • GENE-EXPRESSION

Cite this

Donders, R., Bogie, J. F. J., Ravanidis, S., Gervois, P., Vanheusden, M., Maree, R., Schrynemackers, M., Smeets, H. J. M., Pinxteren, J., Gijbels, K., Walbers, S., Mays, R. W., Deans, R., Van Den Bosch, L., Stinissen, P., Lambrichts, I., Gyselaers, W., & Hellings, N. (2018). Human Wharton's Jelly-Derived Stem Cells Display a Distinct Immunomodulatory and Proregenerative Transcriptional Signature Compared to Bone Marrow-Derived Stem Cells. Stem Cells and Development, 27(2), 65-84. https://doi.org/10.1089/scd.2017.0029